EKF Diagnostics HoldingsLSE:EKF +0.75%54 EBITDA Margin % is 25.72% as of Dec. 2025, which is 15% above its 10-year median of 22.27. GuruFocus rates LSE:EKF with a GF Score™ of 54/100 and a GF Value™ of £0.28 (Fairly Valued). The stock has 4 warning signs investors should review. Among 816 Medical Devices & Instruments companies, EKF Diagnostics Holdings ranks better than 83.7% on this metric.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
EKF Diagnostics Holdings EBITDA Margin % Related Terms
EKF Diagnostics Holdings EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSE:EKF vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, EKF Diagnostics Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EKF Diagnostics Holdings EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, EKF Diagnostics Holdings's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where EKF Diagnostics Holdings's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EKF Diagnostics Holdings (LSE:EKF) has a EBITDA Margin % of 25.72% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on EKF Diagnostics Holdings and its competitors. This is 15% above median its historical median of 22.27. According to the industry distribution chart, EKF Diagnostics Holdings ranks #133 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 16.3%.
Is EKF Diagnostics Holdings' EBITDA Margin % too high?
EKF Diagnostics Holdings' current EBITDA Margin % of 25.72% is 15% above median its 10-year median of 22.27. The Medical Devices & Instruments industry median EBITDA Margin % is 7.48. EKF Diagnostics Holdings' value of 25.72% is 244.1% above this industry median. Based on the distribution chart, EKF Diagnostics Holdings ranks #133 out of 816 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, EKF Diagnostics Holdings has a GF Score™ of 54/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does EKF Diagnostics Holdings' EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, EKF Diagnostics Holdings ranks #133 out of 816 companies for EBITDA Margin %. This places EKF Diagnostics Holdings in the top 16% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 7.48. EKF Diagnostics Holdings' value of 25.72% is 244.1% above this benchmark. While the company's 10-year median is 22.27 vs. the industry median of 7.48, EKF Diagnostics Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EKF Diagnostics Holdings's current EBITDA Margin % of 25.72% is 244.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on EKF Diagnostics Holdings and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EKF Diagnostics Holdings's current EBITDA Margin % is 25.72%, which is 15% above median its own 10-year median of 22.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EKF Diagnostics Holdings stock overvalued right now?
Based on GuruFocus' analysis, EKF Diagnostics Holdings (LSE:EKF) is currently considered Fairly Valued. The stock's GF Value™ is £0.28, compared to a current price of £0.27 — trading 3.6% below its estimated fair value. The current EBITDA Margin % is 25.72%, which is 15% above median its 10-year median of 22.27 and 244.1% above the Medical Devices & Instruments industry median of 7.48. EKF Diagnostics Holdings' overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For EKF Diagnostics Holdings (LSE:EKF), the current EBITDA Margin % is 25.72% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EKF Diagnostics Holdings (LSE:EKF) Overvalued in 2026?
Based on GuruFocus' analysis, EKF Diagnostics Holdings stock appears to be undervalued.
The current stock price of £0.27 is trading 3.6% below its estimated GF Value™ of £0.28.
GuruFocus considers EKF Diagnostics Holdings to be Fairly Valued.
Key valuation signals for LSE:EKF:
EBITDA Margin %: 25.72% (15% above median its 10-year median of 22.27)
GF Value™: £0.28 vs. price of £0.27 (3.6% below fair value)
Industry Position: 244.1% above the Medical Devices & Instruments median (#133 of 816)
No single metric tells the full story. See the LSE:EKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EKF Diagnostics Holdings PLC is engaged in development, manufacture and supply of products and services into the in-vitro diagnostic (IVD) market place. The Group has presence in the UK, USA, Germany, and Russia, and sells throughout the world including Europe, the Middle East, the Americas, Asia, and Africa. It derive their revenue from the manufacture and sale of medical diagnostic equipment and reagents. Other services include the servicing and distribution of third party company products under separate distribution agreements.
54GF Score
Get the complete analysis for LSE:EKF
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:EKF has been successfully added to your 
